New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action

MLA

Rui Liang, et al. New Indication of Chuankezhi Injection for Steroid-Resistant Focal Segmental Glomerulosclerosis and Its Mechanism of Action. June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5ed4846a7327cc4cab454cf8c54821d9&authtype=sso&custid=ns315887.

APA

Rui Liang, Xiang-Na Yang, Shan Lin, Wei-Qing Yi, Xiao-Gang Chen, Xin Dong, Long-Gang Guo, Yan-Kun Li, Yue-Rui Zhao, & Hua Xu. (2022). New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action.

Chicago

Rui Liang, Xiang-Na Yang, Shan Lin, Wei-Qing Yi, Xiao-Gang Chen, Xin Dong, Long-Gang Guo, Yan-Kun Li, Yue-Rui Zhao, and Hua Xu. 2022. “New Indication of Chuankezhi Injection for Steroid-Resistant Focal Segmental Glomerulosclerosis and Its Mechanism of Action,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5ed4846a7327cc4cab454cf8c54821d9&authtype=sso&custid=ns315887.